PACB
Conviction 48IndustrialsScan · Thu, Sep 24, 2026Pacific Biosciences Of California, Inc. (PACB) closed at $1.58 (+12.06%) on Sep 24, 2026. Its latest daily candle is a bullish engulfing. Price is above its 50-day and above its 200-day moving average. RSI(14) 64, RS Rating 79, -40.8% from its 52-week high, -14.1% year to date. Sector: Industrials · LABORATORY ANALYTICAL INSTRUMENTS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PACB
Insider activity
SEC Form 4 transactions in PACB · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Van Oene Mark See Remarks · Common Stock · 2026-08-17 | Sell | 26.91K | $30K | 2026-08-17 | 2026-08-18 |
Van Oene Mark See Remarks · Common Stock · 2026-08-10 | Grant | 489.13K | — | 2026-08-10 | 2026-08-11 |
Van Oene Mark See Remarks · Stock Option (right to buy) · 2026-08-10 | Grant | 1.97M | — | 2026-08-10 | 2026-08-11 |
Ericson William W. Director · Stock Option (right to buy) · 2026-06-03 | Grant | 223.49K | $0 | 2026-06-03 | 2026-06-04 |
LIVINGSTON RANDALL S Director · Stock Option (right to buy) · 2026-06-03 | Grant | 223.49K | $0 | 2026-06-03 | 2026-06-04 |
Smith Christopher M Director · Stock Option (right to buy) · 2026-06-03 | Grant | 223.49K | $0 | 2026-06-03 | 2026-06-04 |
MOHR MARSHALL Director · Stock Option (right to buy) · 2026-06-03 | Grant | 223.49K | $0 | 2026-06-03 | 2026-06-04 |
Gibson Christopher Director · Stock Option (right to buy) · 2026-06-03 | Grant | 74.5K | $0 | 2026-06-03 | 2026-06-04 |
ORDONEZ KATHY Director · Stock Option (right to buy) · 2026-06-03 | Grant | 223.49K | $0 | 2026-06-03 | 2026-06-04 |
MILLIGAN JOHN F Director · Stock Option (right to buy) · 2026-06-03 | Grant | 223.49K | $0 | 2026-06-03 | 2026-06-04 |
SEC filings
EDGAR filings in PACB · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.